Caprock Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,366
Closed -$242K 450
2020
Q1
$242K Buy
1,366
+21
+2% +$3.95K 0.05% 277
2019
Q4
$257K Buy
1,345
+148
+12% +$26.7K 0.05% 273
2019
Q3
$201K Buy
+1,197
New +$195K 0.04% 320
2017
Q4
Sell
-1,569
Closed -$322K 511
2017
Q3
$322K Buy
1,569
+264
+20% +$61.4K 0.07% 268
2017
Q2
$317K Buy
1,305
+210
+19% +$49.3K 0.07% 268
2017
Q1
$262K Buy
1,095
+57
+5% +$13.3K 0.06% 272
2016
Q4
$218K Sell
1,038
-202
-16% -$41.8K 0.05% 299
2016
Q3
$286K Buy
1,240
+176
+17% +$43K 0.06% 267
2016
Q2
$246K Sell
1,064
-3
-0.3% -$692 0.06% 241
2016
Q1
$286K Buy
+1,067
New +$305K 0.07% 235

Other funds holding AGN

Caprock Group's AGN Position: Q2 2020 in Review

Caprock Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,366 shares — an estimated $242K sold.

Caprock Group first reported a position in AGN in Q1 2016 and held it in 10 quarters. The position peaked at $322K in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Caprock Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Caprock Group sold 1,366 Allergan plc shares in Q2 2020, an estimated $242K.
  • Caprock Group first reported a position in Allergan plc in Q1 2016 and held it in 10 quarters.
  • Caprock Group's Allergan plc position peaked at $322K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Caprock Group's 13F filing for Q2 2020, filed 5 Aug 2020.